153 related articles for article (PubMed ID: 16624087)
1. [The association of von Willebrand factor and von Willebrand factor-cleaving protease in systemic lupus erythematosus].
Lu GY; Guo XF; Wang ZY; Bai X; Su J; Ruan CG
Zhonghua Nei Ke Za Zhi; 2006 Jan; 45(1):42-4. PubMed ID: 16624087
[TBL] [Abstract][Full Text] [Related]
2. Significance of plasma von Willebrand factor level and von Willebrand factor-cleaving protease activity in patients with chronic renal diseases.
Lu GY; Shen L; Wang ZY; Guo XF; Bai X; Su J; Ruan CG
Chin Med J (Engl); 2008 Jan; 121(2):133-6. PubMed ID: 18272039
[TBL] [Abstract][Full Text] [Related]
3. Reduced ADAMTS13 activity is associated with thrombotic risk in systemic lupus erythematosus.
Martin-Rodriguez S; Reverter JC; Tàssies D; Espinosa G; Heras M; Pino M; Escolar G; Diaz-Ricart M
Lupus; 2015 Oct; 24(11):1143-9. PubMed ID: 25824235
[TBL] [Abstract][Full Text] [Related]
4. [Residual collagen binding assay for von Willebrand factor-cleaving protease activity and its clinical application].
Gao WQ; Su J; Xing XP; Wang JH; Bai X; Wang ZY; Ruan CG
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2004 Dec; 12(6):726-9. PubMed ID: 15631648
[TBL] [Abstract][Full Text] [Related]
5. Von Willebrand factor cleaving protease (ADAMTS-13) in 123 patients with connective tissue diseases (systemic lupus erythematosus and systemic sclerosis).
Mannucci PM; Vanoli M; Forza I; Canciani MT; Scorza R
Haematologica; 2003 Aug; 88(8):914-8. PubMed ID: 12935979
[TBL] [Abstract][Full Text] [Related]
6. Assessment of the Diagnostic Value of Plasma Levels, Activities, and Their Ratios of von Willebrand Factor and ADAMTS13 in Patients with Cerebral Infarction.
Qu L; Jiang M; Qiu W; Lu S; Zhao Y; Xia L; Ruan C; Zhao Y
Clin Appl Thromb Hemost; 2016 Apr; 22(3):252-9. PubMed ID: 25916953
[TBL] [Abstract][Full Text] [Related]
7. Are increased levels of von Willebrand factor in chronic coronary heart disease caused by decrease in von Willebrand factor cleaving protease activity? A study by an immunoassay with antibody against intact bond 842Tyr-843Met of the von Willebrand factor protein.
He S; Cao H; Magnusson CG; Eriksson-Berg M; Mehrkash M; Schenck-Gustafsson K; Blombäck M
Thromb Res; 2001 Aug; 103(3):241-8. PubMed ID: 11672586
[TBL] [Abstract][Full Text] [Related]
8. Increased plasma von Willebrand factor antigen levels but normal von Willebrand factor cleaving protease (ADAMTS13) activity in preeclampsia.
Molvarec A; Rigó J; Bõze T; Derzsy Z; Cervenak L; Makó V; Gombos T; Udvardy ML; Hársfalvi J; Prohászka Z
Thromb Haemost; 2009 Feb; 101(2):305-11. PubMed ID: 19190814
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of von Willebrand factor-cleaving protease activity in patients with thrombotic thrombocytopenic purpura.
Gao WQ; Su J; Bai X; Wang ZY; Ruan CG
Chin Med J (Engl); 2004 Jun; 117(6):818-22. PubMed ID: 15198879
[TBL] [Abstract][Full Text] [Related]
10. Decreased von Willebrand factor ristocetin cofactor activity and increased ADAMTS13 antigen increase postoperative drainage after coronary artery bypass grafting.
Mazur P; Plicner D; Zdziarska J; Sadowski J; Undas A
Eur J Cardiothorac Surg; 2014 Feb; 45(2):e26-32. PubMed ID: 24351199
[TBL] [Abstract][Full Text] [Related]
11. [A study on the significance of plasma thrombospondin1 in thrombotic thrombocytopenic purpura and the relationship between thrombospondin1 and von Willebrand factor cleaving protease (ADAMTS13)].
Liu F; Lu GY; Dong NZ; Bai X; Su J; Ruan CG
Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(45):3190-3. PubMed ID: 16405838
[TBL] [Abstract][Full Text] [Related]
12. Changes in ADAMTS13 (von-Willebrand-factor-cleaving protease) activity after induced release of von Willebrand factor during acute systemic inflammation.
Reiter RA; Varadi K; Turecek PL; Jilma B; Knöbl P
Thromb Haemost; 2005 Mar; 93(3):554-8. PubMed ID: 15735809
[TBL] [Abstract][Full Text] [Related]
13. [Clinical application of a method for evaluating von Willebrand factor cleaving protease activity].
Lin FQ; Li MF; Liu Q; Li ZY
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Aug; 27(8):1176-9. PubMed ID: 17715019
[TBL] [Abstract][Full Text] [Related]
14. Plasma ADAMTS-13 activity in proliferative lupus nephritis: a large cohort study from China.
Tan Y; Luan ZQ; Hao JB; Song D; Yu F; Zhao MH
Lupus; 2018 Mar; 27(3):389-398. PubMed ID: 28786769
[TBL] [Abstract][Full Text] [Related]
15. Mutations and common polymorphisms in ADAMTS13 gene responsible for von Willebrand factor-cleaving protease activity.
Kokame K; Matsumoto M; Soejima K; Yagi H; Ishizashi H; Funato M; Tamai H; Konno M; Kamide K; Kawano Y; Miyata T; Fujimura Y
Proc Natl Acad Sci U S A; 2002 Sep; 99(18):11902-7. PubMed ID: 12181489
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of plasma von Willebrand factor and its cleaving protease ADAMTS13 in patients with atrial fibrillation.
Freynhofer MK; Gruber SC; Bruno V; Höchtl T; Farhan S; Zaller V; Wojta J; Huber K
Int J Cardiol; 2013 Sep; 168(1):317-25. PubMed ID: 23041092
[TBL] [Abstract][Full Text] [Related]
17. Changes in von Willebrand factor-cleaving protease (ADAMTS13) activity after infusion of desmopressin.
Reiter RA; Knöbl P; Varadi K; Turecek PL
Blood; 2003 Feb; 101(3):946-8. PubMed ID: 12393734
[TBL] [Abstract][Full Text] [Related]
18. Assay of von Willebrand factor (vWF)-cleaving protease based on decreased collagen binding affinity of degraded vWF: a tool for the diagnosis of thrombotic thrombocytopenic purpura (TTP).
Gerritsen HE; Turecek PL; Schwarz HP; Lämmle B; Furlan M
Thromb Haemost; 1999 Nov; 82(5):1386-9. PubMed ID: 10595623
[TBL] [Abstract][Full Text] [Related]
19. Left atrial blood stasis and Von Willebrand factor-ADAMTS13 homeostasis in atrial fibrillation.
Ammash N; Konik EA; McBane RD; Chen D; Tange JI; Grill DE; Herges RM; McLeod TG; Friedman PA; Wysokinski WE
Arterioscler Thromb Vasc Biol; 2011 Nov; 31(11):2760-6. PubMed ID: 21852562
[TBL] [Abstract][Full Text] [Related]
20. Changes in plasma von Willebrand factor and ADAMTS13 levels associated with left atrial remodeling in atrial fibrillation.
Uemura T; Kaikita K; Yamabe H; Soejima K; Matsukawa M; Fuchigami S; Tanaka Y; Morihisa K; Enomoto K; Sumida H; Sugiyama S; Ogawa H
Thromb Res; 2009 May; 124(1):28-32. PubMed ID: 18996572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
